Form 4: Ionis Pharmaceuticals EVP Acquires Shares Under Employee Stock Purchase Plan

Patrick R. O'Neil, EVP, CLO & General Counsel of Ionis Pharmaceuticals, acquired 246 shares of common stock through the company's employee stock purchase plan on August 30, 2024.

Summary

• On August 30, 2024, Patrick R. O'Neil, EVP, CLO & General Counsel of Ionis Pharmaceuticals, acquired 246 shares of common stock.
• The acquisition was made through the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
• The price per share was $38.641.
• Following the transaction, O'Neil directly owns 48,873 shares of Ionis Pharmaceuticals common stock.
• The acquired shares cannot be sold until February 28, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction, and while insider buying can be seen as positive, it's a small amount related to an employee stock purchase plan.

Positives

• The acquisition of shares by a high-ranking executive may signal confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives. It is common for executives to participate in employee stock purchase plans.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through an existing employee program.
• It provides transparency to shareholders regarding insider transactions.

Key Dates